KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

NASDAQ

$26.49

+$0.32 (1.22%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$25.63$27.33

Open $26.15

52 Week Range

$13.25$30.00

Previous Close $26.17

Market Cap1.55B

Volume336.06K

Avg Volume299.48K

P/E (TTM)-10.19

EPS (TTM)$-2.57

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for KESTRA MEDICAL TECHNOLOGIES, LTD.

DEC112025

Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results

Source: GlobeNewsWire•4 days ago

KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the second quarter fiscal 2026, which ended October 31...

DEC32025

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

Source: GlobeNewsWire•13 days ago

KIRKLAND, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd....

DEC22025

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

Source: GlobeNewsWire•13 days ago

KIRKLAND, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd....

DEC12025

Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares

Source: GlobeNewsWire•15 days ago

KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced an underwritten public offering of 5,500,000 common shares. Kestra is offer...

DEC12025

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

Source: GlobeNewsWire•15 days ago

KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026 ended Octob...

NOV102025

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device

Source: GlobeNewsWire•36 days ago

KIRKLAND, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ASSURE® WCD Clinical Evaluation Post-Approval Stud...

NOV42025

Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System

Source: GlobeNewsWire•42 days ago

KIRKLAND, Wash., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd....

OCT282025

Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference

Source: GlobeNewsWire•49 days ago

KIRKLAND, Wash., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd....

OCT72025

Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth

Source: GlobeNewsWire•70 days ago

KIRKLAND, Wash., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd....

SEP252025

Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management

Source: GlobeNewsWire•82 days ago

KIRKLAND, Wash., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced its debut at the 2025 Heart Failure Society of America (HFSA) Annual Scien...